These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 32520799)

  • 1. Natural History of Serum Enzyme Levels in Duchenne Muscular Dystrophy and Implications for Clinical Practice.
    Rodríguez-Cruz M; Almeida-Becerril T; Atilano-Miguel S; Cárdenas-Conejo A; Bernabe-García M
    Am J Phys Med Rehabil; 2020 Dec; 99(12):1121-1128. PubMed ID: 32520799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum transaminase levels in boys with Duchenne and Becker muscular dystrophy.
    McMillan HJ; Gregas M; Darras BT; Kang PB
    Pediatrics; 2011 Jan; 127(1):e132-6. PubMed ID: 21149430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating markers of oxidative stress are associated with a muscle injury in patients with muscular dystrophy Duchenne.
    Almeida-Becerril T; Rodríguez-Cruz M; Raúl Sánchez-González J; Antonio Villaldama-Soriano M; Atilano-Miguel S; Villa-Morales J; Cárdenas-Conejo A; Cárdenas-Vázquez R
    Brain Dev; 2021 Jan; 43(1):111-120. PubMed ID: 32654955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes of serum creatine kinase levels in children with Duchenne muscular dystrophy].
    Sun SC; Peng YS; He JB
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Feb; 10(1):35-7. PubMed ID: 18289468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An examination of some factors influencing creatine kinase in the blood of patients with muscular dystrophy.
    Jackson MJ; Round JM; Newham DJ; Edwards RH
    Muscle Nerve; 1987 Jan; 10(1):15-21. PubMed ID: 3561434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disparities in the diagnostic process of Duchenne and Becker muscular dystrophy.
    Holtzer C; Meaney FJ; Andrews J; Ciafaloni E; Fox DJ; James KA; Lu Z; Miller L; Pandya S; Ouyang L; Cunniff C
    Genet Med; 2011 Nov; 13(11):942-7. PubMed ID: 21836521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed diagnosis of Duchenne muscular dystrophy.
    Mohamed K; Appleton R; Nicolaides P
    Eur J Paediatr Neurol; 2000; 4(5):219-23. PubMed ID: 11030068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidental raised transaminases: a clue to muscle disease.
    Urganci N; Arapoğlu M; Serdaroğlu P; Nuhoğlu A
    Ann Trop Paediatr; 2006 Dec; 26(4):345-8. PubMed ID: 17132300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transaminitis in Duchenne's muscular dystrophy.
    Tay SK; Ong HT; Low PS
    Ann Acad Med Singap; 2000 Nov; 29(6):719-22. PubMed ID: 11269976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidentally Detected Elevated Liver Enzymes: From Liver to Muscle.
    Balaji P; Sankaranarayanan S; Venkataraman V; Sankaranarayanan VS
    Indian Pediatr; 2017 Apr; 54(4):331-332. PubMed ID: 28474596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving recognition of Duchenne muscular dystrophy: a retrospective case note review.
    van Ruiten HJ; Straub V; Bushby K; Guglieri M
    Arch Dis Child; 2014 Dec; 99(12):1074-7. PubMed ID: 25187493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Duchenne muscular dystrophy born prematurely showed normal CK value until 35 weeks of gestation age].
    Morisawa T; Yagi M; Yoshii K; Takeshima Y; Matsuo M
    No To Hattatsu; 2004 Jul; 36(4):342-3. PubMed ID: 15272621
    [No Abstract]   [Full Text] [Related]  

  • 13. Carrier woman of Duchenne muscular dystrophy mimicking inflammatory myositis.
    Yoon J; Kim SH; Ki CS; Kwon MJ; Lim MJ; Kwon SR; Joo K; Moon CG; Park W
    J Korean Med Sci; 2011 Apr; 26(4):587-91. PubMed ID: 21468271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum creatine-kinase (CK) and pyruvate-kinase (PK) activities in Duchenne (DMD) as compared with Becker (BMD) muscular dystrophy.
    Zatz M; Rapaport D; Vainzof M; Passos-Bueno MR; Bortolini ER; Pavanello Rde C; Peres CA
    J Neurol Sci; 1991 Apr; 102(2):190-6. PubMed ID: 2072118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Enzyme diagnosis in progressive muscular dystrophies, especially in the Duchenne type].
    Pernice W; Beckmann R; Renner S; Wais U
    Klin Padiatr; 1989; 201(3):167-76. PubMed ID: 2739342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and disease monitoring biomarkers in Duchenne muscular dystrophy: results from a Phase II trial.
    Wagner KR; Guglieri M; Ramaiah SK; Charnas L; Marraffino S; Binks M; Vaidya VS; Palmer J; Goldstein R; Muntoni F
    Biomark Med; 2021 Oct; 15(15):1389-1396. PubMed ID: 34533053
    [No Abstract]   [Full Text] [Related]  

  • 17. Oral creatine supplementation in Duchenne muscular dystrophy: a clinical and 31P magnetic resonance spectroscopy study.
    Felber S; Skladal D; Wyss M; Kremser C; Koller A; Sperl W
    Neurol Res; 2000 Mar; 22(2):145-50. PubMed ID: 10763500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duchenne muscular dystrophy and idiopathic hyperCKemia in the same family.
    Eeg-Olofsson O; Kalimo H; Eeg-Olofsson KE; Jagell S; Marklund L; Simonsson L; Dahl N
    Eur J Paediatr Neurol; 2008 Sep; 12(5):404-7. PubMed ID: 18833644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isoenzyme distribution of creatine kinase and lactate dehydrogenase in serum and skeletal muscle in Duchenne muscular dystrophy, collagen disease, and other muscular disorders.
    Yasmineh WG; Ibrahim GA; Abbasnezhad M; Awad EA
    Clin Chem; 1978 Nov; 24(11):1985-9. PubMed ID: 709832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic and clinical significance of the titin fragment in urine of Duchenne muscular dystrophy patients.
    Awano H; Matsumoto M; Nagai M; Shirakawa T; Maruyama N; Iijima K; Nabeshima YI; Matsuo M
    Clin Chim Acta; 2018 Jan; 476():111-116. PubMed ID: 29175173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.